Beijing Bionovo Medicine Development Co., Ltd.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Beijing China (2003)

Organization Overview

First Clinical Trial
2011
NCT01569516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now